Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-19-043367
Filing Date
2019-11-14
Accepted
2019-11-14 07:38:09
Documents
6
Period of Report
2019-11-14

Document Format Files

Seq Description Document Type Size
1 6-K bntx-6k_20191114.htm 6-K 17822
2 EX-99.1 bntx-ex991_6.htm EX-99.1 53909
3 EX-99.2 bntx-ex992_7.htm EX-99.2 1200183
4 GRAPHIC gv31zx4bjtiw000003.jpg GRAPHIC 6369
5 GRAPHIC gv31zx4bjtiw000002.jpg GRAPHIC 17226
6 GRAPHIC gv31zx4bjtiw000001.jpg GRAPHIC 3411
  Complete submission text file 0001564590-19-043367.txt   1310530
Mailing Address AN DER GOLDGRUBE 12 MAINZ 2M 55131
Business Address AN DER GOLDGRUBE 12 MAINZ 2M 55131 0049613190847081
BioNTech SE (Filer) CIK: 0001776985 (see all company filings)

EIN.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39081 | Film No.: 191216355
SIC: 2836 Biological Products, (No Diagnostic Substances)